Critical Role of STAT5 Transcription Factor Tetramerization for Cytokine Responses and Normal Immune Function

Immunity

Volumn 36, Issue 4, 2012, Pages 586-599

  Lin, Jian Xin ^a   Li, Peng ^a   Liu, Delong ^b   Jin, Hyun Tak ^c   He, Jianping ^d   Rasheed, Mohammed Ata Ur ^c   Rochman, Yrina ^a   Wang, Lu ^a   Cui, Kairong ^a   Liu, Chengyu ^a   Kelsall, Brian L ^d   Ahmed, Rafi ^c   Leonard, Warren J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; STAT5 PROTEIN; TETRAMER;

ANIMAL EXPERIMENT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONSENSUS; CONTROLLED STUDY; CYTOKINE RESPONSE; GENE CONTROL; HOMEOSTASIS; IMMUNE RESPONSE; LETHALITY; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SURVIVAL; VIRUS INFECTION;

ANIMALS; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; COLITIS; CYTOKINES; DNA-BINDING PROTEINS; GENE KNOCK-IN TECHNIQUES; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, TRANSGENIC; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 84859968982     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.02.017     Document Type: Article

References (43)

1. Bailey T.L., Elkan C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 1994, 2:28-36.
2. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.
3. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Stat3 as an oncogene. Cell 1999, 98:295-303.
4. Campbell D.J., Koch M.A. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 2011, 11:119-130.
5. Chen X., Bhandari R., Vinkemeier U., Van Den Akker F., Darnell J.E., Kuriyan J. A reinterpretation of the dimerization interface of the N-terminal domains of STATs. Protein Sci. 2003, 12:361-365.
6. Chiarle R., Simmons W.J., Cai H., Dhall G., Zamo A., Raz R., Karras J.G., Levy D.E., Inghirami G. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat. Med. 2005, 11:623-629.
7. Copeland N.G., Gilbert D.J., Schindler C., Zhong Z., Wen Z., Darnell J.E., Mui A.L., Miyajima A., Quelle F.W., Ihle J.N., et al. Distribution of the mammalian Stat gene family in mouse chromosomes. Genomics 1995, 29:225-228.
8. Cui Y., Riedlinger G., Miyoshi K., Tang W., Li C., Deng C.X., Robinson G.W., Hennighausen L. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol. Cell. Biol. 2004, 24:8037-8047.
9. Darnell J.E. STATs and gene regulation. Science 1997, 277:1630-1635.
10. Hou Z., Srivastava S., Mistry M.J., Herbst M.P., Bailey J.P., Horseman N.D. Two tandemly linked interferon-gamma-activated sequence elements in the promoter of glycosylation-dependent cell adhesion molecule 1 gene synergistically respond to prolactin in mouse mammary epithelial cells. Mol. Endocrinol. 2003, 17:1910-1920.
11. Imada K., Bloom E.T., Nakajima H., Horvath-Arcidiacono J.A., Udy G.B., Davey H.W., Leonard W.J. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J. Exp. Med. 1998, 188:2067-2074.
12. Jenkins D., Balsitis M., Gallivan S., Dixon M.F., Gilmour H.M., Shepherd N.A., Theodossi A., Williams G.T. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. J. Clin. Pathol. 1997, 50:93-105. The British Society of Gastroenterology Initiative.
13. John S., Robbins C.M., Leonard W.J. An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO J. 1996, 15:5627-5635.
14. John S., Vinkemeier U., Soldaini E., Darnell J.E., Leonard W.J. The significance of tetramerization in promoter recruitment by Stat5. Mol. Cell. Biol. 1999, 19:1910-1918.
15. Kaech S.M., Wherry E.J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2002, 2:251-262.
16. Kelly J.A., Spolski R., Kovanen P.E., Suzuki T., Bollenbacher J., Pise-Masison C.A., Radonovich M.F., Lee S., Jenkins N.A., Copeland N.G., et al. Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma. J. Exp. Med. 2003, 198:79-89.
17. Kim H.P., Kelly J., Leonard W.J. The basis for IL-2-induced IL-2 receptor alpha chain gene regulation: importance of two widely separated IL-2 response elements. Immunity 2001, 15:159-172.
18. Leonard W.J., O'Shea J.J. Jaks and STATs: biological implications. Annu. Rev. Immunol. 1998, 16:293-322.
19. Levy D.E., Darnell J.E. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 2002, 3:651-662.
20. Lin J.X., Mietz J., Modi W.S., John S., Leonard W.J. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J. Biol. Chem. 1996, 271:10738-10744.
21. Liu X., Robinson G.W., Wagner K.U., Garrett L., Wynshaw-Boris A., Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 1997, 11:179-186.
22. Mandal M., Powers S.E., Maienschein-Cline M., Bartom E.T., Hamel K.M., Kee B.L., Dinner A.R., Clark M.R. Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2. Nat. Immunol. 2011, 12:1212-1220.
23. Meyer W.K., Reichenbach P., Schindler U., Soldaini E., Nabholz M. Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor alpha gene transcription. J. Biol. Chem. 1997, 272:31821-31828.
24. Moriggl R., Topham D.J., Teglund S., Sexl V., McKay C., Wang D., Hoffmeyer A., van Deursen J., Sangster M.Y., Bunting K.D., et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 1999, 10:249-259.
25. Munson, P.J. (2001). GeneLogic Workshop of Low Level Analysis of Affymetrix GeneChip Data (). http://abs.cit.nih.gov/geneexpression.html.
26. Nakajima H., Liu X.W., Wynshaw-Boris A., Rosenthal L.A., Imada K., Finbloom D.S., Hennighausen L., Leonard W.J. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity 1997, 7:691-701.
27. Ota N., Brett T.J., Murphy T.L., Fremont D.H., Murphy K.M. N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. Nat. Immunol. 2004, 5:208-215.
28. Powrie F., Leach M.W., Mauze S., Menon S., Caddle L.B., Coffman R.L. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1994, 1:553-562.
29. Robinson M.D., McCarthy D.J., Smyth G.K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26:139-140.
30. Rochman Y., Spolski R., Leonard W.J. New insights into the regulation of T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 2009, 9:480-490.
31. Socolovsky M., Fallon A.E., Wang S., Brugnara C., Lodish H.F. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 1999, 98:181-191.
32. Soldaini E., John S., Moro S., Bollenbacher J., Schindler U., Leonard W.J. DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites. Mol. Cell. Biol. 2000, 20:389-401.
33. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D., Brown M., Bodner S., Grosveld G., Ihle J.N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998, 93:841-850.
34. Udy G.B., Towers R.P., Snell R.G., Wilkins R.J., Park S.H., Ram P.A., Waxman D.J., Davey H.W. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 1997, 94:7239-7244.
35. Verdier F., Rabionet R., Gouilleux F., Beisenherz-Huss C., Varlet P., Muller O., Mayeux P., Lacombe C., Gisselbrecht S., Chretien S. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B. Mol. Cell. Biol. 1998, 18:5852-5860.
36. Vinkemeier U., Cohen S.L., Moarefi I., Chait B.T., Kuriyan J., Darnell J.E. DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J. 1996, 15:5616-5626.
37. Vinkemeier U., Moarefi I., Darnell J.E., Kuriyan J. Structure of the amino-terminal protein interaction domain of STAT-4. Science 1998, 279:1048-1052.
38. Wherry E.J., Blattman J.N., Murali-Krishna K., van der Most R., Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 2003, 77:4911-4927.
39. Xu X., Sun Y.L., Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 1996, 273:794-797.
40. Yamamoto K., Shibata F., Miyasaka N., Miura O. The human perforin gene is a direct target of STAT4 activated by IL-12 in NK cells. Biochem. Biophys. Res. Commun. 2002, 297:1245-1252.
41. Yao Z., Cui Y., Watford W.T., Bream J.H., Yamaoka K., Hissong B.D., Li D., Durum S.K., Jiang Q., Bhandoola A., et al. Stat5a/b are essential for normal lymphoid development and differentiation. Proc. Natl. Acad. Sci. USA 2006, 103:1000-1005.
42. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 2009, 9:798-809.
43. Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., Nusbaum C., Myers R.M., Brown M., Li W., Liu X.S. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008, 9:R137.